Ironshore Pharms Drug Patent Portfolio
Ironshore Pharms owns 1 orange book drug protected by 16 US patents Given below is the list of Ironshore Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10182995 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US10292937 | Methods of treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US10617651 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US10881618 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US10905652 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US11241391 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US11241392 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US11911518 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US8916588 | Methods for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US8927010 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US9023389 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US9028868 | Methods and compositions for treatment of attention deficit disorder | 23 Mar, 2032 | Active |
| US9034902 | Methods for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US9283214 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US9498447 | Compositions for treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
| US9603809 | Methods of treatment of attention deficit hyperactivity disorder | 23 Mar, 2032 | Active |
Latest Legal Activities on Ironshore Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ironshore Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 17 Jul, 2024 | US10905652 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 19 Jun, 2024 | US10881618 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 May, 2024 | US9498447 |
|
Email Notification
Critical
| 08 May, 2024 | US11911518 |
|
Email Notification
Critical
| 07 May, 2024 | US11911518 |
| Recordation of Patent eCertificate of Correction | 07 May, 2024 | US11911518 |
| Mail Patent eCofC Notification | 07 May, 2024 | US11911518 |
| Patent eCofC Notification | 07 May, 2024 | US11911518 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 20 Mar, 2024 | US10881618 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 20 Mar, 2024 | US11241392 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 20 Mar, 2024 | US10905652 |
| Patent eGrant Notification | 27 Feb, 2024 | US11911518 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Feb, 2024 | US11911518 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Feb, 2024 | US11911518 |
| Recordation of Patent eGrant | 27 Feb, 2024 | US11911518 |
Ironshore Pharms's Family Patents
Ironshore Pharms drugs have patent protection in a total of 14 countries. It's US patent count contributes only to 49.1% of its total global patent coverage. Click
below to unlock the full patent family tree.
Ironshore Pharms Drug List
Given below is the complete list of Ironshore Pharms's drugs and the patents protecting them.
1. Jornay Pm
Jornay Pm is protected by 16 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10182995 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US10292937 | Methods of treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US10617651 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US10881618 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US10905652 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US11241391 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US11241392 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US11911518 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US8916588 | Methods for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US8927010 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US9023389 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US9028868 | Methods and compositions for treatment of attention deficit disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US9034902 | Methods for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US9283214 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US9498447 | Compositions for treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
| US9603809 | Methods of treatment of attention deficit hyperactivity disorder |
23 Mar, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jornay Pm's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List